Abstract
This case reports the unique association of eosinophilic gastrointestinal disease with eosinophilic bronchitis, asthma and chronic rhinosinusitis and some features of lymphocytic hypereosinophilic syndrome, describes a diagnostic protocol for patients with asthma and persistent eosinophilic bronchitis, and suggests that the use of a novel EPX-mAb provides a reliable method to identify eosinophilic inflammation.
| Original language | English (US) |
|---|---|
| Article number | 4 |
| Journal | Allergy, Asthma and Clinical Immunology |
| Volume | 7 |
| Issue number | 1 |
| DOIs | |
| State | Published - Mar 1 2011 |
Fingerprint
ASJC Scopus subject areas
- Immunology and Allergy
- Pulmonary and Respiratory Medicine
- Immunology
Cite this
The identification of eosinophilic gastroenteritis in prednisone-dependent eosinophilic bronchitis and asthma. / Nair, Parameswaran; Ochkur, Sergei I.; Protheroe, Cheryl; Simms, Elizabeth; Lee, Nancy A; Lee, James J.
In: Allergy, Asthma and Clinical Immunology, Vol. 7, No. 1, 4, 01.03.2011.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - The identification of eosinophilic gastroenteritis in prednisone-dependent eosinophilic bronchitis and asthma
AU - Nair, Parameswaran
AU - Ochkur, Sergei I.
AU - Protheroe, Cheryl
AU - Simms, Elizabeth
AU - Lee, Nancy A
AU - Lee, James J.
PY - 2011/3/1
Y1 - 2011/3/1
N2 - This case reports the unique association of eosinophilic gastrointestinal disease with eosinophilic bronchitis, asthma and chronic rhinosinusitis and some features of lymphocytic hypereosinophilic syndrome, describes a diagnostic protocol for patients with asthma and persistent eosinophilic bronchitis, and suggests that the use of a novel EPX-mAb provides a reliable method to identify eosinophilic inflammation.
AB - This case reports the unique association of eosinophilic gastrointestinal disease with eosinophilic bronchitis, asthma and chronic rhinosinusitis and some features of lymphocytic hypereosinophilic syndrome, describes a diagnostic protocol for patients with asthma and persistent eosinophilic bronchitis, and suggests that the use of a novel EPX-mAb provides a reliable method to identify eosinophilic inflammation.
UR - http://www.scopus.com/inward/record.url?scp=84862140940&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84862140940&partnerID=8YFLogxK
U2 - 10.1186/1710-1492-7-4
DO - 10.1186/1710-1492-7-4
M3 - Article
C2 - 21362188
AN - SCOPUS:84862140940
VL - 7
JO - Allergy, Asthma and Clinical Immunology
JF - Allergy, Asthma and Clinical Immunology
SN - 1710-1484
IS - 1
M1 - 4
ER -